There is potential for a device such as FINDER to assist in the implementation of the new American Academy of Pediatrics’s guidelines for G6PD testing in newborns with recurring high bilirubin concentrations [17], as well as testing for G6PD deficiency prior to rasburicase therapy [10]. This evidence concerns the gene G6PD and G6PD deficiency.